FDA label
What is Austedo used for?
Austedo contains deutetrabenazine. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “AUSTEDO XR® and AUSTEDO® are indicated in adults for the treatment of: chorea associated with Huntington’s disease; tardive dyskinesia.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Austedo?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Austedo, tablet, coated
Indications and Usage, quoted from the label by Teva Neuroscience, Inc. (NDA208082). Cross-references to other label sections are left out.
AUSTEDO XR® and AUSTEDO® are indicated in adults for the treatment of:
- chorea associated with Huntington’s disease
- tardive dyskinesia
Source: DailyMed label, set id 7ea3c60a-45c7-44cc-afc2-d87fa53993c0, version 36, effective February 28, 2025. NDC 68546-170, one of 3 listings for this product.
Questions
What is Austedo used for?
The FDA label says: “AUSTEDO XR® and AUSTEDO® are indicated in adults for the treatment of: chorea associated with Huntington’s disease; tardive dyskinesia.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.